237 related articles for article (PubMed ID: 27251416)
1. Pediatric Dispersible Tablets: a Modular Approach for Rapid Prototyping.
Buck J; Huwyler J; Kühl P; Dischinger A
Pharm Res; 2016 Aug; 33(8):2043-55. PubMed ID: 27251416
[TBL] [Abstract][Full Text] [Related]
2. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
[TBL] [Abstract][Full Text] [Related]
3. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
Chandrasekaran P; Kandasamy R
AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets.
Douroumis DD; Gryczke A; Schminke S
AAPS PharmSciTech; 2011 Mar; 12(1):141-51. PubMed ID: 21181510
[TBL] [Abstract][Full Text] [Related]
5. Aceclofenac fast dispersible tablet formulations: Effect of different concentration levels of Avicel PH102 on the compactional, mechanical and drug release characteristics.
Yasmin R; Shoaib MH; Ahmed FR; Qazi F; Ali H; Zafar F
PLoS One; 2020; 15(2):e0223201. PubMed ID: 32050259
[TBL] [Abstract][Full Text] [Related]
6. Prediction of oral disintegration time of fast disintegrating tablets using texture analyzer and computational optimization.
Szakonyi G; Zelkó R
Int J Pharm; 2013 May; 448(2):346-53. PubMed ID: 23558313
[TBL] [Abstract][Full Text] [Related]
7. Formulation and characterization of oral rapid disintegrating tablets of levocetirizine.
Samvedna S; Jindal S; Mishra G; Madan JR; Gupta G; Awasthi R; Pinto TJA; Dua K; Kulkarni GT
Polim Med; 2018; 48(1):31-40. PubMed ID: 30657656
[TBL] [Abstract][Full Text] [Related]
8. Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.
Zaheer K; Langguth P
Drug Dev Ind Pharm; 2018 Mar; 44(3):444-451. PubMed ID: 29098885
[TBL] [Abstract][Full Text] [Related]
9. Co-Processed Excipients for Dispersible Tablets-Part 1: Manufacturability.
Bowles BJ; Dziemidowicz K; Lopez FL; Orlu M; Tuleu C; Edwards AJ; Ernest TB
AAPS PharmSciTech; 2018 Aug; 19(6):2598-2609. PubMed ID: 29916193
[TBL] [Abstract][Full Text] [Related]
10. Fast dispersible ibuprofen tablets.
Schiermeier S; Schmidt PC
Eur J Pharm Sci; 2002 Apr; 15(3):295-305. PubMed ID: 11923062
[TBL] [Abstract][Full Text] [Related]
11. Novel levocetirizine HCl tablets with enhanced palatability: synergistic effect of combining taste modifiers and effervescence technique.
Labib GS
Drug Des Devel Ther; 2015; 9():5135-46. PubMed ID: 26379426
[TBL] [Abstract][Full Text] [Related]
12. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets.
Devireddy SR; Gonugunta CS; Veerareddy PR
PDA J Pharm Sci Technol; 2009; 63(6):521-6. PubMed ID: 20169858
[TBL] [Abstract][Full Text] [Related]
13. The Milky Way: paediatric milk-based dispersible tablets prepared by direct compression - a proof-of-concept study.
Orubu SE; Hobson NJ; Basit AW; Tuleu C
J Pharm Pharmacol; 2017 Apr; 69(4):417-431. PubMed ID: 27349946
[TBL] [Abstract][Full Text] [Related]
14. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25.
Solaiman A; Suliman AS; Shinde S; Naz S; Elkordy AA
Int J Pharm; 2016 Mar; 501(1-2):87-95. PubMed ID: 26827922
[TBL] [Abstract][Full Text] [Related]
15. Testing the disintegration and texture-related palatability predictions for orodispersible tablets using an instrumental tool coupled with multivariate analysis: Focus on process variables and analysis settings.
Iovanov R; Cornilă A; Bogdan C; Hales D; Tomuță I; Achim M; Tăut A; Iman N; Casian T; Iurian S
Eur J Pharm Sci; 2024 Jul; 198():106801. PubMed ID: 38754594
[TBL] [Abstract][Full Text] [Related]
16. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets.
Chandrasekhar R; Hassan Z; Alhusban F; Smith AM; Mohammed AR
Eur J Pharm Biopharm; 2009 May; 72(1):119-29. PubMed ID: 19073253
[TBL] [Abstract][Full Text] [Related]
17. Ocimum Sanctum seeds, a natural superdisintegrant: formulation and evaluation of fast melt tablets of nimesulide.
Malik K; Arora G; Singh I
Polim Med; 2012; 42(1):49-59. PubMed ID: 22783733
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of a Novel Method to Evaluate Water Permeation Rates by Combining the Dynamic Contact Angle and Thermographic Approach: Significance of Disintegration Properties of Orally Disintegrating Tablets].
Suzuki T; Kurano T; Kanazawa T; Suzuki N
Yakugaku Zasshi; 2020; 140(8):1071-1080. PubMed ID: 32741865
[TBL] [Abstract][Full Text] [Related]
19. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
Kasliwal N; Negi JS; Jugran V; Jain R
Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
[TBL] [Abstract][Full Text] [Related]
20. Influence of Prosolv and Prosolv:Mannitol 200 direct compression fillers on the physicomechanical properties of atorvastatin oral dispersible tablets.
Gowda V; Pabari RM; Kelly JG; Ramtoola Z
Pharm Dev Technol; 2015 Jun; 20(4):394-400. PubMed ID: 24397821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
